A Phase II Trial Of Gemcitabine And Triapine In Refractory Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2013
At a glance
- Drugs OCX 191 (Primary) ; Gemcitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 15 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 16 Aug 2005 New trial record.